Third Nerve Palsy: Rare Adverse Event following Covid-19 Vaccination
Drugs Controller General of India (DCGI) in April 2022 approved the emergency use authorisation of Corbevax and Covaxin COVID 19 vaccines in children. Corbevax is a protein subunit COVID 19 vaccine developed by Texas Children's Hospital. Third nerve palsy is rarely reported following protein s...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Research Center for Rational Use of Drugs (RCRUD),
2024-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
| Call Number: |
A1234.567 |
|---|---|
| Copy 1 | Available |